GlassScriptPhysician profile
Sherry D Miller
NPI 1194048413
$1,007.82
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $33.18 · 2022: $16.70 · 2023: $514 · 2024: $444.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $958.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $957.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $265.57 | 2023-2024 | Rybelsus, Ozempic, Wegovy |
| Lilly USA, LLC | $149.60 | 2023-2024 | Mounjaro, Jardiance, Emgality |
| Abbvie INC. | $118.95 | 2023-2024 | |
| Astrazeneca Pharmaceuticals LP | $103.90 | 2023-2024 | Breztri, Airsupra, Farxiga |
| Astellas Pharma US INC | $100.53 | 2023-2024 | Veozah |
| Glaxosmithkline, LLC. | $89.60 | 2023-2024 | Trelegy Ellipta |
| Exact Sciences Corporation | $40.09 | 2024 | Cologuard Collection Kit |
| Takeda Pharmaceuticals U.S.A., INC. | $31.95 | 2023-2024 | Trintellix |
| Abbott Laboratories | $21.58 | 2023 | Freestyle Libre 2 |
| Janssen Pharmaceuticals, INC | $21.22 | 2023 | Xarelto |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $18.20 | 2021 | |
| Rxsight INC | $16.70 | 2022 | |
| Alfasigma USA, INC. | $14.98 | 2021 | |
| Lundbeck LLC | $14.95 | 2023 | Abilify Maintena |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sherry Miller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.